Amomum xanthiodes inhibits mast cell-mediated allergic reactions through the inhibition of histamine release and inflammatory cytokine production

Experimental Biology and Medicine

Volumn 230, Issue 9, 2005, Pages 681-687

  Kim, Sang Hyun ^a   Shin, Tae Yong ^b  

^a Kyungpook National University School of Medicine   (South Korea)

^b Woosuk University   (South Korea)

Author keywords

Amomum xanthiodes; cAMP; Histamine; Intracellular Ca2+; Mast cells; Nuclear factor B; Tumor necrosis factor interleukin 6

Indexed keywords

AMOMUM XANTHIODES EXTRACT; CALCIMYCIN; CALCIUM ION; CROMOGLYCATE DISODIUM; CYTOKINE; HISTAMINE; I KAPPA B; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; PHORBOL 13 ACETATE 12 MYRISTATE; PLANT EXTRACT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALLERGIC REACTION; ANALYTIC METHOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HISTAMINE RELEASE; HUMAN; HUMAN CELL; MALE; MAST CELL; MOUSE; NONHUMAN; PERITONEUM MAST CELL; PROTEIN DEGRADATION; RAT;

AMOMUM; ANIMALIA; ZINGIBERACEAE;

EID: 27144520916     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/153537020523000911     Document Type: Article

References (34)

1. Metcalfe DD, Kaliner M, Donlon MA. The mast cell. Crit Rev Immunol 3:23-74, 1981.
2. Miyajima I, Dombrowicz D, Martin TR, Ravetch JV, Kinet JP, Galli SJ. Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and Fc gammaRIII. Assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE- or IgG1-dependent passive anaphylaxis. J Clin Invest 99:901-914, 1997.
3. Church MK, Levi-Schaffer F. The human mast cell. J Allergy Clin Immunol 99:155-160, 1997.
4. Petersen LJ, Mosbech H, Skov PS. Allergen-induced histamine release in intact human skin in vivo assessed by skin microdialysis technique: characterization of factors influencing histamine releasability. J Allergy Clin Immunol 97:672-679, 1996.
5. Ennis M, Pearce FL, Weston PM. Some studies on the release of histamine from mast cells stimulated with polylysine. Br J Pharmacol 70:329-334, 1980.
6. Alfonso A, Cabado AG, Vieytes MR, Botana LM. Functional compartments in rat mast cells for cAMP and calcium on histamine release. Cell Signal 12:343-350, 2000.
7. Beaven MA, Rogers J, Moore JP, Hesketh TR, Smith GA, Metcalfe JC. The mechanism of the calcium signal and correlation with histamine release in 2H3 cells. J Biol Chem 259:7129-7136, 1984.
8. Beaven MA, Metzger H. Signal transduction by Fc receptors: the Fc epsilon RI case. Immunol Today 14:222-226, 1993.
9. Alm PE. Modulation of mast cell cAMP levels. A regulatory function of calmodulin. Int Arch Allergy Appl Immunol 75:375-378, 1984.
10. Botana LM, MacGlashan DW. Differential effects of cAMP-elevating drugs on stimulus-induced cytosolic calcium changes in human basophils. J Leukoc Biol 55:798-804, 1994.
11. Bradding P, Feather IH, Wilson S, Bardin PG, Heusser CH, Holgate ST, Howarth PH. Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation. J Immunol 151:3853-3865, 1993.
12. Burd PR, Rogers HW, Gordon JR, Martin CA, Jayaraman S, Wilson SD , Dvorak AM, Galli SJ, Dorf ME. Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines. J Exp Med 170:245-257, 1989.
13. Plaut M, Pierce JH, Watson CJ, Hanley-Hyde J, Nordan RP, Paul WE. Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores. Nature 339:64-67, 1989.
14. Azzolina A, Bongiovanni A, Lampiasi N. Substance P induces TNF-alpha and IL-6 production through NF kappa B in peritoneal mast cells. Biochim Biophys Acta 1643:75-83, 2003.
15. Ou M. Chinese-English Manual of Common-Used in Traditional Chinese Medicine. Hong Kong: Joint Publishing, p154, 1992.
16. Kitajima J, Ishikawa T. Water-soluble constituents of amomum seed. Chem Pharm Bull (Tokyo) 51:890-893, 2003.
17. Kwon KB, Kim JH, Lee YR, Lee HY, Jeong YJ, Rho HW, Ryu DG, Park JW, Park BH. Amomum xanthoides extract prevents cytokine-induced cell death of RINm5F cells through the inhibition of nitric oxide formation. Life Sci 73:181-191, 2003.
18. Kim SH, Choi CH, Kim SY, Eun JS, Shin TY. Anti-allergic effects of Artemisia iwayomogi on mast cell-mediated allergy model. Exp Biol Med (Maywood) 230:82-88, 2005.
19. Shore PA, Burkhalter A, Cohn VH Jr. A method for the fluorometric assay of histamine in tissues. J Pharmacol Exp Ther 127:182-186, 1959.
20. Peachell PT, MacGlashan DW Jr, Lichtenstein LM, Schleimer RP. Regulation of human basophil and lung mast cell function by cyclic adenosine monophosphate. J Immunol 140:571-579, 1988.
21. Kim SH, Sharma RP. Mercury-induced apoptosis and necrosis in murine macrophages: role of calcium-induced reactive oxygen species and p38 mitogen-activated protein kinase signaling. Toxicol Appl Pharmacol 196:47-57, 2004.
22. Cox JS. Disodium cromoglycate (FPL 670) ('Intal'): a specific inhibitor of reaginic antibody-antigen mechanisms. Nature 216:1328-1329, 1967.
23. Kemp SF, Lockey RF. Anaphylaxis: a review of causes and mechanisms. J Allergy Clin Immunol 110:341-348, 2002.
24. Mousli M, Bronner C, Bockaert J, Rouot B, Landry Y. Interaction of substance P, compound 48/80 and mastoparan with the alpha-subunit C-terminus of G protein. Immunol Lett 25:355-357, 1990.
25. Chahdi A, Fraundorfer PF, Beaven MA. Compound 48/80 activates mast cell phospholipase D via heterotrimeric GTP-binding proteins. J Pharmacol Exp Ther 292:122-130, 2000.
26. Kaliner M, Austen KF. Cyclic AMP, ATP, and reversed anaphylactic histamine release from rat mast cells. J Immunol 112:664-74, 1974.
27. Tasaka K, Mio M, Okamoto M. Intracellular calcium release induced by histamine releasers and its inhibition by some antiallergic drugs. Ann Allergy 56:464-469, 1986.
28. Weston MC, Peachell PT. Regulation of human mast cell and basophil function by cAMP. Gen Pharmacol 31:715-719, 1998.
29. Moller A, Henz BM, Grutzkau A, Lippert U, Aragane Y, Schwarz T, Kruger-Krasagakes S. Comparative cytokine gene expression: regulation and release by human mast cells. Immunology 93:289-295, 1998.
30. Sillaber C, Bevec D, Butterfield JH, Heppner C, Valenta R, Scheiner O, Kraft D, Lechner K, Bettelheim P, Valent P. Tumor necrosis factor alpha and interleukin-1 beta mRNA expression in HMC-1 cells: differential regulation of gene product expression by recombinant interleukin-4. Exp Hematol 21:1271-1275, 1993.
31. Walsh LJ, Trinchieri G, Waldorf HA, Whitaker D, Murphy GF. Human dermal mast cells contain and release tumor necrosis factor alpha, which induces endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci U S A 88:4220-4224, 1991.
32. Mican JA, Arora N, Burd PR, Metcalfe DD. Passive cutaneous anaphylaxis in mouse skin is associated with local accumulation of interleukin-6 mRNA and immunoreactive interleukin-6 protein. J Allergy Clin Immunol 90:815-824, 1992.
33. Collart MA, Baeuerle P, Vassalli P. Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B. Mol Cell Biol 10:1498-1506, 1990.
34. Arbabi S, Maier RV. Mitogen-activated protein kinases. Crit Care Med 30:S74-S79, 2002.